[1] Epidemiologic and methodologic problems in determining nutritional status of older persons. Proceedings of a conference. Albuquerque, New Mexico, October 19-21, 1988[J]. Am J Clin Nutr, 1989, 50(5 Suppl): 1121-1235.
[2] CRUZ-JENTOFT A J, BAHAT G, BAUER J, et al. Sarcopenia: revised European consensus on definition and diagnosis[J]. Age Ageing, 2019, 48(1): 16-31.
[3] CHEN L K, LIU L K, WOO J, et al. Sarcopenia in Asia: consensus report of the Asian Working Group for Sarcopenia[J]. J Am Med Dir Assoc, 2014, 15(2): 95-101.
[4] FLEGAL K M, KRUSZON-MORAN D, CARROLL M D, et al. Trends in obesity among adults in the United States, 2005 to 2014[J]. Jama, 2016, 315(21): 2284-2291.
[5] BAUMGARTNER R N, WAYNE S J, WATERS D L, et al. Sarcopenic obesity predicts instrumental activities of daily living disability in the elderly[J]. Obes Res, 2004, 12(12): 1995-2004.
[6] CAWTHONP M. Assessment of lean mass and physical performance in sarcopenia[J]. J Clin Densitom, 2015, 18(4): 467-471.
[7] BOSY-WESTPHAL A, JENSEN B, BRAUN W, et al. Quantification of whole-body and segmental skeletal muscle mass using phase-sensitive 8-electrode medical bioelectrical impedance devices[J]. Eur J Clin Nutr, 2017, 71(9): 1061-1067.
[8] WOODROW G. Body composition analysis techniques in the aged adult: indications and limitations[J]. Curr Opin Clin Nutr Metab Care, 2009, 12(1): 8-14.
[9] ERLANDSON M C, LORBERGS A L, MATHUR S, et al. Muscle analysis using pQCT, DXA and MRI[J]. Eur J Radiol, 2016, 85(8): 1505-1511.
[10] SCOTT D, CUMMING R, NAGANATHAN V, et al. Associations of sarcopenic obesity with the metabolic syndrome and insulin resistance over five years in older men: The Concord Health and Ageing in Men Project[J]. Exp Gerontol, 2018, 108: 99-105.
[11] FUKUDA T, BOUCHI R, TAKEUCHI T, et al. Sarcopenic obesity assessed using dual energy X-ray absorptiometry (DXA) can predict cardiovascular disease in patients with type 2 diabetes: a retrospective observational study[J]. Cardiovasc Diabetol, 2018, 17(1): 55.
[12] MENG P, HU Y X, FAN L, et al. Sarcopenia and sarcopenic obesity among men aged 80 years and older in Beijing: prevalence and its association with functional performance[J]. Geriatr Gerontol Int, 2014, 14 Suppl 1: 29-35.
[13] AIBAR-ALMAZÁN A, MARTINEZ-AMAT A, CRUZ-DIAZ D, et al. Sarcopenia and sarcopenic obesity in Spanish community-dwelling middle-aged and older women: Association with balance confidence, fear of falling and fall risk[J]. Maturitas, 2018, 107: 26-32.
[14] BATSIS J A, MACKENZIE T A, BARRE L K, et al. Sarcopenia, sarcopenic obesity and mortality in older adults: results from the National Health and Nutrition Examination Survey III[J]. Eur J Clin Nutr, 2014, 68(9): 1001-1007.
[15] LU C W, YANG K C, CHANG H H, et al. Sarcopenic obesity is closely associated with metabolic syndrome[J]. Obes Res Clin Pract, 2013, 7(4): e301-307.
[16] NEWMAN A B, KUPELIAN V, VISSER M, et al. Sarcopenia: alternative definitions and associations with lower extremity function[J]. J Am Geriatr Soc, 2003, 51(11): 1602-1609.
[17] PERNA S, SPADACCINI D, RONDANELLI M. Sarcopenic obesity: time to target the phenotypes[J]. J Cachexia Sarcopenia Muscle, 2019, 10(3): 710-711.
[18] LIM S, KIM J H, YOON J W, et al. Sarcopenic obesity: prevalence and association with metabolic syndrome in the Korean Longitudinal Study on Health and Aging (KLoSHA)[J]. Diabetes Care, 2010, 33(7): 1652-1654.
[19] BAEK S J, NAM G E, HAN K D, et al. Sarcopenia and sarcopenic obesity and their association with dyslipidemia in Korean elderly men: the 2008-2010 Korea National Health and Nutrition Examination Survey[J]. J Endocrinol Invest, 2014, 37(3): 247-260.
[20] KIM T N, PARK M S, LIM K I, et al. Relationships between sarcopenic obesity and insulin resistance, inflammation, and vitamin D status: the Korean Sarcopenic Obesity Study[J]. Clin Endocrinol (Oxf), 2013, 78(4): 525-532.
[21] HIRANI V, NAGANATHAN V, BLYTH F, et al. Longitudinal associations between body composition, sarcopenic obesity and outcomes of frailty, disability, institutionalisation and mortality in community-dwelling older men: The Concord Health and Ageing in Men Project[J]. Age Ageing, 2017, 46(3): 413-420.
[22] SCOTT D, SEIBEL M, CUMMING R, et al. Sarcopenic obesity and its temporal associations with changes in bone mineral density, incident falls, and fractures in older men: The Concord Health And Ageing In Men Project[J]. J Bone Miner Res, 2017, 32(3): 575-583.
[23] SCOTT D, SANDERS K M, AITKEN D, et al. Sarcopenic obesity and dynapenic obesity: 5-year associations with falls risk in middle-aged and older adults[J]. Obesity (Silver Spring), 2014, 22(6): 1568-1574.
[24] ZHANG X, XIE X, DOU Q, et al. Association of sarcopenic obesity with the risk of all-cause mortality among adults over a broad range of different settings: A updated meta-analysis[J]. BMC Geriatr, 2019, 19(1): 183.
[25] ROSSI A P, ANTIN F F, CALIARI C, et al. Dynapenic abdominal obesity as predictor of mortality and disability worsening in older adults: A 10-year prospective study[J]. Clin Nutr, 2016, 35(1): 199-204.
[26] ATKINS J L, WHINCUPP H, MORRIS R W, et al. Sarcopenic obesity and risk of cardiovascular disease and mortality: a population-based cohort study of older men[J]. J Am Geriatr Soc, 2014, 62(2): 253-260.
[27] TOLEA M I, CHRISPHONTE S, GALVIN J E. Sarcopenic obesity and cognitive performance[J]. Clin Interv Aging, 2018,13: 1111-1119.
[28] ÖZTÜRK Z A, TÜRKBEYLER? H, ABIYEV A, et al. Health-related quality of life and fall risk associated with age-related body composition changes; sarcopenia, obesity and sarcopenic obesity[J]. Intern Med J, 2018, 48(8): 973-981.
[29] CHEN H T, CHUNG Y C, CHEN Y J, et al. Effects of different types of exercise on body composition, muscle strength, and IGF-1 in the elderly with sarcopenic obesity[J]. J Am Geriatr Soc, 2017, 65(4): 827-832.
[30] KIM H, KIM M, KOJIMA N, et al. Exercise and nutritional supplementation on community-dwelling elderly Japanese women with sarcopenic obesity: A randomized controlled trial[J]. J Am Med Dir Assoc, 2016, 17(11): 1011-1019. |
